Angiotensin Neprilysin Inhibition for Patients With Heart Failure What If Sacubitril/Valsartan Were a Treatment for Cancer?

被引：18
|
作者：
Packer, Milton [1 ]
机构：
[1] Baylor Univ, Med Ctr, Baylor Heart & Vasc Inst, 621 N Hall St, Dallas, TX 75226 USA
来源：
JAMA CARDIOLOGY | 2016年 / 1卷 / 09期
关键词：
ENALAPRIL;
D O I：
10.1001/jamacardio.2016.3053
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：971 / 972
页数：2
相关论文
共 50 条
  • [1] Entresto (Sacubitril/Valsartan): Angiotensin Receptor Neprilysin Inhibition for Treating Heart Failure
    Nicholas Phreaner
    Barry H. Greenberg
    Current Emergency and Hospital Medicine Reports, 2017, 5 (2) : 47 - 55
  • [2] Neprilysin inhibition with sacubitril/valsartan in the treatment of heart failure: mortality bang for your buck
    Ansara, A. J.
    Kolanczyk, D. M.
    Koehler, J. M.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (02) : 119 - 127
  • [3] Dual Angiotensin Receptor and Neprilysin Inhibition with Sacubitril/Valsartan in Chronic Systolic Heart Failure: Understanding the New PARADIGM
    Lillyblad, Matthew P.
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (11) : 1237 - 1251
  • [4] Entresto (Sacubitril/Valsartan): First-in-Class Angiotensin Receptor Neprilysin Inhibitor FDA Approved for Patients with Heart Failure
    Fala, Loretta
    AMERICAN HEALTH AND DRUG BENEFITS, 2015, 8 (06):
  • [5] Sacubitril/valsartan in patients with heart failure and a history of cancer
    Frey, M. K.
    Arfsten, H.
    Pavo, N.
    Han, E.
    Huelsmann, M.
    Gyoengyoesi, M.
    Bergler-Klein, J.
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S225 - S225
  • [6] The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan
    Jhund, Pardeep S.
    McMurray, John J. V.
    HEART, 2016, 102 (17) : 1342 - 1347
  • [7] LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor (ARNI): clinical development in heart failure
    Martin P Lefkowitz
    BMC Pharmacology and Toxicology, 16 (Suppl 1)
  • [8] Effectiveness of sacubitril-valsartan in cancer patients with heart failure
    Martin-Garcia, Ana
    Lopez-Fernandez, Teresa
    Mitroi, Cristina
    Chaparro-Munoz, Marinela
    Moliner, Pedro
    Martin-Garcia, Agustin C.
    Martinez-Monzonis, Amparo
    Castro, Antonio
    Lopez-Sendon, Jose L.
    Sanchez, Pedro L.
    ESC HEART FAILURE, 2020, 7 (02): : 763 - 767
  • [9] The PARAGON Heart Failure trial - ongoing investigation of the angiotensin receptor antagonist/neprilysin inhibitor sacubitril/valsartan in heart failure patients with hypertension and preserved ejection fraction
    Kjeldsen, Sverre E.
    Narkiewicz, Krzysztof
    Burnier, Michel
    Oparil, Suzanne
    BLOOD PRESSURE, 2019, 28 (04) : 215 - 216
  • [10] Who 'nose', is it the angiotensin receptor neprilysin inhibitor?: a case series of persistent nasal pruritus in heart failure patients receiving sacubitril/valsartan
    Gan, Jaclyn
    Rheault, Haunnah
    Wong, Yee Weng
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2021, 5 (12)
12345